| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 14056* | 2021 |
| The evolution of iron chelators for the treatment of iron overload disease and cancer DS Kalinowski, DR Richardson Pharmacological reviews 57 (4), 547-583, 2005 | 916 | 2005 |
| The molecular mechanisms of the metabolism and transport of iron in normal and neoplastic cells DR Richardson, P Ponka Biochimica Et Biophysica Acta (BBA)-Reviews on Biomembranes 1331 (1), 1-40, 1997 | 900 | 1997 |
| Lipid-based drug delivery systems in cancer therapy: what is available and what is yet to come P Yingchoncharoen, DS Kalinowski, DR Richardson, EL Barker Pharmacological reviews 68 (3), 701-787, 2016 | 791 | 2016 |
| Function and regulation of transferrin and ferritin. P Ponka, C Beaumont, DR Richardson Seminars in hematology 35 (1), 35-54, 1998 | 780 | 1998 |
| Unraveling the mysteries of serum albumin—more than just a serum protein AM Merlot, DS Kalinowski, DR Richardson Frontiers in physiology 5, 299, 2014 | 726 | 2014 |
| The role of iron in cell cycle progression and the proliferation of neoplastic cells NTV Le, DR Richardson Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1603 (1), 31-46, 2002 | 604 | 2002 |
| Iron uptake and metabolism in the new millennium LL Dunn, YS Rahmanto, DR Richardson Trends in cell biology 17 (2), 93-100, 2007 | 592 | 2007 |
| A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics M Whitnall, J Howard, P Ponka, DR Richardson Proceedings of the National Academy of Sciences 103 (40), 14901-14906, 2006 | 586 | 2006 |
| Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol DR Richardson, DJR Lane, EM Becker, MLH Huang, M Whitnall, ... Proceedings of the National Academy of Sciences 107 (24), 10775-10782, 2010 | 579 | 2010 |
| Thiosemicarbazones from the old to new: iron chelators that are more than just ribonucleotide reductase inhibitors Y Yu, DS Kalinowski, Z Kovacevic, AR Siafakas, PJ Jansson, C Stefani, ... Journal of medicinal chemistry 52 (17), 5271-5294, 2009 | 483 | 2009 |
| Novel di-2-pyridyl–derived iron chelators with marked and selective antitumor activity: in vitro and in vivo assessment J Yuan, DB Lovejoy, DR Richardson Blood 104 (5), 1450-1458, 2004 | 453 | 2004 |
| Dipyridyl thiosemicarbazone chelators with potent and selective antitumor activity form iron complexes with redox activity DR Richardson, PC Sharpe, DB Lovejoy, D Senaratne, DS Kalinowski, ... Journal of medicinal chemistry 49 (22), 6510-6521, 2006 | 445 | 2006 |
| Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease DJR Lane, AM Merlot, MLH Huang, DH Bae, PJ Jansson, S Sahni, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1853 (5), 1130-1144, 2015 | 422 | 2015 |
| The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents DR Richardson, EH Tran, P Ponka | 413 | 1995 |
| Iron trafficking in the mitochondrion: novel pathways revealed by disease I Napier, P Ponka, DR Richardson Blood 105 (5), 1867-1874, 2005 | 358 | 2005 |
| Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and … NTV Le, DR Richardson Blood 104 (9), 2967-2975, 2004 | 355 | 2004 |
| Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents DR Richardson, DS Kalinowski, S Lau, PJ Jansson, DB Lovejoy Biochimica et Biophysica Acta (BBA)-General Subjects 1790 (7), 702-717, 2009 | 341 | 2009 |
| Novel aroylhydrazone and thiosemicarbazone iron chelators with anti-malarial activity against chloroquine-resistant and-sensitive parasites A Walcourt, M Loyevsky, DB Lovejoy, VR Gordeuk, DR Richardson The international journal of biochemistry & cell biology 36 (3), 401-407, 2004 | 328 | 2004 |
| Antitumor activity of metal-chelating compound Dp44mT is mediated by formation of a redox-active copper complex that accumulates in lysosomes DB Lovejoy, PJ Jansson, UT Brunk, J Wong, P Ponka, DR Richardson Cancer research 71 (17), 5871-5880, 2011 | 320 | 2011 |
Zaklina KovacevicUniversity of SydneyVerified email at sydney.edu.au
